-

Columbia Care Announces Board Change

NEW YORK--(BUSINESS WIRE)--Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) announces that effective today, Mr. Igor Gimelshtein will be transitioning from his role as an Independent Director to a Board Observer position.

“On behalf of the entire Board of Directors, I wish to thank Igor for his contributions and guidance over the past several years, particularly as we transitioned to the public markets,” said Michael Abbott, Executive Chairman of Columbia Care. “I am also delighted that Igor will remain engaged and involved as a Board Observer, so that the Company can continue to benefit from his broad industry knowledge.”

Added Mr. Gimelshtein, “It has been a pleasure to work so closely with the Board of Directors and management team of Columbia Care. I am proud of what we have accomplished together and believe strongly in what the Company has built and will achieve. I am very much looking forward to continuing our work together as a Board Observer and providing on-going support and advice."

As a result of Mr. Gimelshtein’s transition, the nominees for election to Columbia Care’s Board of Directors at its Annual Meeting of Shareholders are:

01 – Nicholas Vita
02 – Michael Abbott
03 – Frank Savage
04 – James A.C. Kennedy
05 – Jonathan P. May
06 – Jeff Clarke

Annual Meeting of Shareholders and Webcast Details

This year, out of an abundance of caution, to proactively deal with the public health impact of the recent Coronavirus outbreak, also known as COVID-19, and to mitigate the risks to the health and safety of our communities, Shareholders, employees and other stakeholders, we will hold the Meeting in a virtual only format, which will be conducted via live audio webcast.

The Meeting will be held on Monday, June 8th, 2020 at 3:45 p.m. EDT and can be accessed online at https://web.lumiagm.com/298550642 .

About Columbia Care Inc.

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of medical and adult use cannabis products and related services with licenses in 18 US jurisdictions1 and the EU. Columbia Care has completed more than 1.8 million sales transactions since inception and working in collaboration with renowned and innovative teaching hospitals and medical centers globally, continues to be a patient-centered health and wellness company setting the standard for compassion, professionalism, quality, care and innovation in the rapidly expanding cannabis industry. For more information on Columbia Care, please visit www.col-care.com.

____________________

1 Includes Colorado, subject to successful completion of the acquisition of The Green Solution and W. Virginia industrial hemp cultivation license

 

Contacts

Investor Contact:
Gary F. Santo, Jr.
Investor Relations
+1.212.271.0915
gsanto@col-care.com

Media Contact:
Gabriella Velez
5WPR
columbiacare@5wpr.com

Columbia Care Inc.

NEO:CCHW

Release Versions

Contacts

Investor Contact:
Gary F. Santo, Jr.
Investor Relations
+1.212.271.0915
gsanto@col-care.com

Media Contact:
Gabriella Velez
5WPR
columbiacare@5wpr.com

More News From Columbia Care Inc.

The Cannabist Company to Report Second Quarter 2025 Results on August 7, 2025

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), today announced that it will report its financial results for the second quarter ended June 30, 2025 before U.S. financial markets open on Thursday, August 7, 2025. Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EST. Conference Call and Webcast Details To access the live conference call via...

The Cannabist Company Introduces COAST Cannabis Co. Edibles to Maryland Market

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., announced today the launch of COAST Cannabis Co. edibles in Maryland, bringing a new selection of premium, function-forward gummies to adult-use consumers and medical patients alike. This launch marks the first step in the partnership between The Ca...

The Cannabist Company Announces Director Appointments

CHELMSFORD, Mass.--(BUSINESS WIRE)--The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: CBSTF) (“The Cannabist Company” or the “Company”), one of the most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., is pleased to announce the appointment of independent directors, Tom Lynch and Peter Lee, to its Board of Directors effective today, in accordance with the terms of the Amended and Restated Indenture dated May 29, 2025, entered into in connection wi...
Back to Newsroom